Rule 8.3 - Neuropharm Group Plc


 
TIDMZZZ TIDMNPH 
 
FORM 8.3 
 
    DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE 
                         (Rule 8.3 of the Takeover Code) 
 
 
1.   KEY INFORMATION 
 
Name of person dealing        Mr Trevor & Mrs Jeanette Lambarth 
(Note 1) 
Company dealt in              Neuropharm Group Plc 
Class of relevant security    10p Ordinary 
to which the dealings being 
disclosed relate (Note 2) 
Date of dealing               23 March 2010 (Mr & Mrs Lambarth dealt on 
                              previous dates during the Offer period as 
                              set out in this Form) 
 
 
2.   INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE 
 
(a)  Interests and short positions (following dealing) in the class of relevant 
security dealt in (Note 3) 
 
                                        Long                  Short 
 
                                    Number     (%)        Number      (%) 
 
(1) Relevant securities            770,000    2.44 
 
(2)  Derivatives (other  than 
options) 
 
(3) Options and agreements 
to purchase/sell 
 
Total                              770,000    2.44 
 
 
(b)  Interests and short positions in relevant securities of the company, other 
     than the class dealt in (Note 3) 
 
Class of relevant security:           Long                  Short 
 
                              Number                Number 
                              (%)                   (%) 
(1) Relevant securities 
 
(2)  Derivatives (other  than 
options) 
 
(3) Options and agreements 
to purchase/sell 
 
Total 
 
 
(c)  Rights to subscribe (Note 3) 
 
Class of relevant security:   Details 
 
 
 
 
 
3.   DEALINGS (Note 4) 
 
(a)  Purchases and sales 
 
Purchase/sale            Number of securities    Price per unit (Note 5) 
Purchase                 30,000                  0.0983 
 
 Mr & Mrs Lambarth have also carried out the following dealings which have 
 not previously been disclosed : 
 
 
Date               Purchase / Sale    Number of          Price per Unit 
                                      Securities 
3 November 2009    Purchase           20,000             0.1810 
3 November 2009    Purchase           25,000             0.1988 
17 December 2009   Purchase           20,000             0.1350 
17 December 2009   Purchase           55,000             0.1250 
4 January 2010     Purchase           30,000             0.1275 
4 January 2010     Purchase           20,000             0.1260 
4 January 2010     Purchase           30,000             0.1150 
11 February 2010   Purchase           20,000             0.0900 
12 February 2010   Purchase           40,000             0.0800 
12 March 2010      Purchase           20,000             0.1200 
12 March 2010      Purchase           30,000             0.1135 
22 March 2010      Purchase           30,000             0.1085 
 
 
 
(b)  Derivatives transactions (other than options) 
 
Product name, Long/short       Number of securities   Price per unit 
e.g. CFD      (Note 6)         (Note 7)               (Note 5) 
 
 
 
(c)  Options transactions in respect of existing securities 
 
(i)  Writing, selling, purchasing or varying 
 
Product name, Writing,     Number of    Exercise   Type,    Expiry   Option 
e.g. call     selling,     securities   price      e.g.     date     money 
option        purchasing,  to which the            American,         paid/received 
              varying      option                  European          per unit 
              etc.         relates                 etc.              (Note 5) 
                           (Note 7) 
 
 
(ii) Exercising 
 
Product name, e.g. call  Number of securities    Exercise price per unit 
option                                           (Note 5) 
 
 
 
(d)  Other dealings (including new securities) (Note 4) 
 
 
Nature of transaction    Details                 Price per unit (if 
(Note 8)                                         applicable) (Note 5) 
 
 
 
 
4.   OTHER INFORMATION 
Agreements, arrangements or understandings relating to options or derivatives 
 
 
Full details of any agreement, arrangement or understanding between the 
person disclosing and any other person relating to the voting rights of 
any relevant securities under any option referred to on this form or 
relating to the voting rights or future acquisition or disposal of any 
relevant securities to which any derivative referred to on this form is 
referenced.  If none, this should be stated. 
 
 
NONE 
 
 
Is a Supplemental Form 8 attached? (Note 9)                 NO 
 
 
Date of disclosure                         25 March 2010 
Contact name                               Mr T Lambarth 
Telephone number                           01420 82707 
If a connected EFM, name of                N /A 
offeree/offeror with which connected 
If a connected EFM, state nature of        N/A 
connection (Note 10) 
 
 
Notes 
 
The Notes on Form 8.3 can be viewed on the Takeover Panel's website at 
www.thetakeoverpanel.org.uk
Neuropharm (LSE:NPH)
過去株価チャート
から 5 2024 まで 6 2024